125
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Gastric gastrointestinal stromal tumors: therapeutic strategies and long-term prognosis

, , , , , & ORCID Icon show all
Pages 239-245 | Received 13 Jun 2023, Accepted 09 Oct 2023, Published online: 22 Oct 2023

References

  • Ducimetiere F, Lurkin A, Ranchere-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLOS One. 2011;6(8):e20294. doi: 10.1371/journal.pone.0020294.
  • Joensuu H, Vehtari A, Riihimaki J, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265–274. doi: 10.1016/S1470-2045(11)70299-6.
  • Piessen G, Lefevre JH, Cabau M, et al. Laparoscopic versus open surgery for gastric gastrointestinal stromal tumors: what is the impact on postoperative outcome and oncologic results? Ann Surg. 2015;262(5):831–840. doi: 10.1097/SLA.0000000000001488.
  • Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol. 2005;29(10):1373–1381. doi: 10.1097/01.pas.0000172190.79552.8b.
  • Goh BK, Goh YC, Eng AK, et al. Outcome after laparoscopic versus open wedge resection for suspected gastric gastrointestinal stromal tumors: a matched-pair case-control study. Eur J Surg Oncol. 2015;41(7):905–910. doi: 10.1016/j.ejso.2015.04.001.
  • Soreide K, Sandvik OM, Soreide JA, et al. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46. doi: 10.1016/j.canep.2015.10.031.
  • Holmebakk T, Hompland I, Bjerkehagen B, et al. Recurrence-Free survival after resection of gastric gastrointestinal stromal tumors classified according to a strict definition of tumor rupture: a Population-Based study. Ann Surg Oncol. 2018;25(5):1133–1139. doi: 10.1245/s10434-018-6353-5.
  • Casali PG, Blay JY, Abecassis N, et al. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(1):20–33. doi: 10.1016/j.annonc.2021.09.005.
  • Dematteo RP, Gold JS, Saran L, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer. 2008;112(3):608–615. doi: 10.1002/cncr.23199.
  • Giuliano K, Nagarajan N, Canner J, et al. Gastric and small intestine gastrointestinal stromal tumors: do outcomes differ? J Surg Oncol. 2017;115(3):351–357. doi: 10.1002/jso.24514.
  • Li J, Ye Y, Wang J, et al. Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor. Chin J Cancer Res 2017; 29(4): 281–293. doi: 10.21147/j.issn.1000-9604.2017.04.01.
  • Koo DH, Ryu MH, Kim KM, et al. Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor. Cancer Res Treat. 2016;48(4):1155–1166. doi: 10.4143/crt.2016.187.
  • Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39(10):1411–1419. doi: 10.1016/j.humpath.2008.06.025.
  • Deprez PH, Moons LMG, OʼToole D, et al. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2022;54(4):412–429. doi: 10.1055/a-1751-5742.
  • Andalib I, Yeoun D, Reddy R, et al. Endoscopic resection of gastric gastrointestinal stromal tumors originating from the muscularis propria layer in North America: methods and feasibility data. Surg Endosc. 2018;32(4):1787–1792. doi: 10.1007/s00464-017-5862-9.
  • Wang C, Gao Z, Shen K, et al. Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: a systematic review and meta-analysis. Eur J Surg Oncol. 2020;46(4 Pt A):667–674. doi: 10.1016/j.ejso.2019.10.030.
  • Kim HH. Endoscopic treatment for gastrointestinal stromal tumor: advantages and hurdles. World J Gastrointest Endosc. 2015;7(3):192–205. doi: 10.4253/wjge.v7.i3.192.
  • An W, Sun PB, Gao J, et al. Endoscopic submucosal dissection for gastric gastrointestinal stromal tumors: a retrospective cohort study. Surg Endosc. 2017;31(11):4522–4531. doi: 10.1007/s00464-017-5511-3.
  • Pang T, Zhao Y, Fan T, et al. Comparison of safety and outcomes between endoscopic and surgical resections of small (</= 5 cm) primary gastric gastrointestinal stromal tumors. J Cancer. 2019;10(17):4132–4141. doi: 10.7150/jca.29443.
  • Jeong ID, Jung SW, Bang SJ, et al. Endoscopic enucleation for gastric subepithelial tumors originating in the muscularis propria layer. Surg Endosc. 2011;25(2):468–474. doi: 10.1007/s00464-010-1195-7.
  • Bischof DA, Kim Y, Dodson R, et al. Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomes. Ann Surg Oncol. 2014;21(9):2941–2948. doi: 10.1245/s10434-014-3733-3.
  • Dai WJ, Liu G, Wang M, et al. Endoscopic versus laparoscopic resection of gastric gastrointestinal stromal tumors: a multicenter study. Oncotarget. 2017;8(7):11259–11267. doi: 10.18632/oncotarget.13298.
  • Wilhelm D, von Delius S, Burian M, et al. Simultaneous use of laparoscopy and endoscopy for minimally invasive resection of gastric subepithelial masses - analysis of 93 interventions. World J Surg. 2008;32(6):1021–1028. doi: 10.1007/s00268-008-9492-1.
  • Miettinen M, Makhlouf H, Sobin LH, et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immuno­histochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30(4):477–489. doi: 10.1097/00000478-200604000-00008.
  • Liu X, Qiu H, Zhang P, et al. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China. Cancer Med. 2017;6(12):2796–2803. doi: 10.1002/cam4.1229.
  • Casali PG, Le Cesne A, Velasco AP, et al. Final analysis of the randomized trial on imatinib as an adjuvant in localized Gastrointestinal Stromal Tumors (GIST) from the EORTC soft tissue and bone sarcoma group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish group for research on sarcomas (GEIS. Ann Oncol. 2021;32(4):533–541. doi: 10.1016/j.annonc.2021.01.004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.